# Sazerac North America, Inc. – FDA Inspection, Sep 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/sazerac-north-america-inc/5af65e0c-2ade-453a-9cc9-ea248c89202f
Source feed: FDA_Inspections

> FDA inspection 1181313 of Sazerac North America, Inc., September 19, 2022. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181313
- Company Name: Sazerac North America, Inc.
- Inspection Date: 2022-09-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 980254 - 2016-08-03

Company: https://www.keypedia.com/companies/sazerac-north-america-inc/6f9d24ea-e2bf-4957-9878-1264814b381d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c